Treatment outcomes in symptomatic Dientamoeba fragilis infection: a prospective clinical and molecular study
DF should be considered in patients with unexplained chronic gastrointestinal symptoms. Molecular testing is recommended for accurate diagnosis. Paromomycin appears to be the most effective treatment, with a strong association between clinical recovery and microbiological cure. Randomized controlled trials are warranted to further define optimal management strategies for DF infection.
Authors
- Asaf Biber (ORCID: https://orcid.org/0000-0001-6007-0383)
- Eli Schwartz (ORCID: https://orcid.org/0000-0002-4673-9084)
- Dafna Yahav
Institutions
- Tel Aviv University (IL)
- Sheba Medical Center (IL)
Publication Details
- Journal
- Infection
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1007/s15010-026-02746-6
- Primary Topic
- Parasitic Infections and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00